Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
about
Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approachMaximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper-Lin small composite design.Original research paper. Characterization and taste masking evaluation of microparticles with cetirizine dihydrochloride and methacrylate-based copolymer obtained by spray drying.In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.Combined Effect of Synthetic and Natural Polymers in Preparation of Cetirizine Hydrochloride Oral Disintegrating Tablets: Optimization by Central Composite DesignTaste masking of naproxen sodium granules by fluid-bed coating.Bitterness evaluation of intact and crushed Vesicare orally disintegrating tablets using taste sensors.An in-vivo and in-vitro taste masking evaluation of bitter melt-extruded drugs.Use of extrusion aids for successful production of Kollidon® CL-SF pellets by extrusion-spheronization.Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.Taste masking of azithromycin by resin complex and sustained release through interpenetrating polymer network with functionalized biopolymers.Organic-aqueous crossover coating process for the desmopressin orally disintegrating microparticles.Rapid Dynamic Determination of Cetirizine Dihydrochloride in Urine Using Surface Enhanced Raman Scattering with Silver Colloids
P2860
Q34265134-90D8A3F4-8F7D-4E5C-BB07-FCF55CB9D7E5Q36631651-0D8CE306-20CC-4AA8-B54C-D2F81B931553Q38946027-206CD387-EDEC-4FA4-9E01-67DD4AF13D59Q39520757-58DDDC68-EF40-4F4B-8DA4-A229C4D5FA3CQ42047805-E86AE6E5-D17B-426A-8B5F-DB90FF1FD20FQ43507575-F70FFA63-CBD8-4910-9C77-7CE26F0E33B1Q44095496-B8AD31C2-7258-424E-9893-84228F11EE38Q45722754-5FF8327B-1EDA-4EC4-B258-B6F4A6B0D138Q47594816-759CC6AC-0E3A-4797-8BBA-EFA13CB2F7DAQ48612739-BEA2C2A9-F467-4CDC-9E37-9D3B5BB1A4A0Q52936245-6F0230BA-FCE9-4C01-A42C-E744B802DDD1Q53307774-74BEC64A-D341-48D2-BFA3-CD4B8935C290Q58189498-D0BFABBF-35AE-42D7-8003-AC328CC32568
P2860
Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
@ast
Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
@en
Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
@nl
type
label
Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
@ast
Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
@en
Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
@nl
prefLabel
Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
@ast
Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
@en
Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
@nl
P2093
P2860
P1433
P1476
Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets
@en
P2093
Andreas Gryczke
Dionysios Dennis Douroumis
Silke Schminke
P2860
P2888
P304
P356
10.1208/S12249-010-9569-7
P407
P577
2010-12-23T00:00:00Z
P5875
P6179
1050109490